Cancer survivors and those with cardiovascular diseases have an increased risk of developing colorectal cancer and breast cancer. Undergoing colorectal cancer screening and mammogram uptake within the recommended intervals have the potential to improve early detection. However, the potential impact of cancer history and cardiovascular disease on colorectal cancer screening and mammogram uptake remains unexamined.
Methods
We conducted a cross-sectional analysis of 2019, 2021, and 2023 National Health Interview Survey data. Our outcomes of interest were up-to-date colorectal cancer screening and mammogram uptake. Our exposures of interest were cancer history and cardiovascular disease. We used weighted multivariable logistic regressions to examine these associations and adjusted for sociodemographic characteristics, healthcare access, and the year respondents took the survey.
Results
Most respondents had up-to-date colorectal cancer screening (73.1%) and mammogram uptake (77.8%). Most respondents did not report a history of cancer (colorectal cancer screening sample: 85.1%, mammogram uptake sample: 84.6%) or cardiovascular disease (colorectal cancer screening sample: 87.7%, mammogram uptake sample: 90.1%). Having a history of cancer was associated with increased odds of having up-to-date colorectal cancer screening (OR, 1.74, 95% CI, 1.56–1.95). However, respondents with cardiovascular disease, but no cancer history, had decreased odds of mammogram uptake (OR: 0.79, 95% CI: 0.68–0.91).
Discussion
The history of cancer was associated with increased colorectal cancer screening uptake. Contrarily, cardiovascular diseases were associated with decreased mammogram uptake. Generally, healthcare providers should emphasize the importance of up-to-date colorectal cancer screening and mammogram uptake. However, our findings suggest that primary care and educational initiatives tailored toward those with cardiovascular disease that aim to improve mammogram uptake are needed.
KcMFanJHyslopT, et al.Relative burden of cancer and noncancer mortality among long-term survivors of breast, prostate, and colorectal cancer in the US. JAMA Netw OpenJul 3 2023; 6: e2323115.
2.
MehtaLSWatsonKEBaracA, et al.Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation2018; 137: e30–e66.
3.
ZhangTZhuHHuH, et al.Cardiovascular-specific mortality and risk factors in colorectal cancer patients: a cohort study based on registry data of over 500,000 individuals in the US. Prev Med2024; 179: 107796.
4.
ZhangSWangYZhangP, et al.Cardiovascular outcomes in the patients with colorectal cancer: a multi-registry-based cohort study of 197,699 cases in the real world. Front Cardiovasc Med2022; 9: 851833.
5.
CherukuriSPChikatimallaRDasaradhanT, et al.Breast cancer and the cardiovascular disease: a narrative review. CureusAug 2022; 14: e27917.
SauderCAMLiQBoldRJ, et al.Secondary breast cancer sociodemographic characteristics and survival by age group. Ann Surg OncolDec 2021; 28: 8118–8127.
8.
DengZJonesMRWangM-C, et al.Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study. NPJ Breast Cancer2022; 8: 82.
9.
BellCFLeiXHaasA, et al.Risk of cancer after diagnosis of cardiovascular disease. JACC CardioOncolAug 2023; 5: 431–440.
10.
CorkumMHaydenJAKephartG, et al.Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer SurvivSep 2013; 7: 455–463.
11.
DesautelsDCzaykowskiPNugentZ, et al.Risk of colorectal cancer after the diagnosis of prostate cancer: a population-based study. Cancer2016; 122: 1254–1260.
12.
DoninNFilsonCDrakakiA, et al.Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. CancerOct 2016; 122: 3075–3086.
MortonLMOnelKCurtisRE, et al.The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book2014; 34: e57–e67.
15.
SuzukiMTomoikeHSumiyoshiT, et al.Incidence of cancers in patients with atherosclerotic cardiovascular diseases. IJC Heart & Vasculature2017; 17: 11–16.
16.
ZhangCChengYLuoD, et al.Association between cardiovascular risk factors and colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. EClinicalMedicine2021; 34: 100794.
17.
LiuLShiYLiT, et al.Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies. Br J Sports Med2016; 50: 372–378.
18.
EliassenAHHankinsonSERosnerB, et al.Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med2010; 170: 1758–1764.
19.
HardefeldtPJPenninkilampiREdirimanneS, et al.Physical activity and weight loss reduce the risk of breast cancer: a meta-analysis of 139 prospective and retrospective studies. Clin Breast Cancer2018; 18: e601–e612.
GhozySZayanAHEl-QushayriAE, et al.Physical activity level and stroke risk in US population: a matched case-control study of 102,578 individuals. Ann Clin Transl Neurol2022; 9: 264–275.
22.
RothGAMensahGAJohnsonCO, et al.Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol2020; 76: 2982–3021.
23.
TonorezosEDevasiaTMariottoAB, et al.Prevalence of cancer survivors in the United States. JNCI: Journal of the National Cancer Institute2024; 116: 1784–1790.
24.
ZhangJChenGLiZ, et al.Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis. J Cancer2020; 11: 5953–5970.
25.
ShaukatAMonginSJGeisserMS, et al.Long-term mortality after screening for colorectal cancer. N Engl J Med2013; 369: 1106–1114.
26.
KowalskiAE. Mammograms and mortality: how has the evidence evolved?J Econ Perspect2021; 35: 119–140.
27.
DavidsonKWBarryMJMangioneCM, et al.Screening for colorectal cancer: US preventive services task force recommendation statement. Jama2021; 325: 1965–1977.
28.
SiuAL. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med2016; 164: 279–296.
29.
US Preventive Services Task Force. Screening for breast cancer: US preventive services task force recommendation statement. JAMA2024; 331: 1918–1930.
30.
HudsonSVHahnKAOhman-StricklandP, et al.Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices. J Gen Intern Med2009; 24: S487–S490.
31.
HoldenDJJonasDEPorterfieldDS, et al.Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med2010; 152: 668–676.
32.
GuoFHirthJMBerensonAB. Effects of cardiovascular disease on compliance with cervical and breast cancer screening recommendations among adult women. J Womens Health (Larchmt)2015; 24: 641–647.
33.
LiuBYO'MalleyJMoriM, et al.The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Fam Med2014; 27: 669–681.
34.
SakhujaSFowlerMEOjesinaAI. Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. Prev Med Rep2021; 21: 101263.
35.
MatsumuraKKakiuchiYTabuchiT, et al.Cancer screening: possibility of underscreening in older adult population with a history of cardiovascular disease. J Cardiol2022; 80: 133–138.
36.
Castañeda-AvilaMALapaneKLJesdaleBM, et al.Variation in colorectal cancer screening practices according to cardiovascular disease status and race/ethnicity. J Racial Ethn Health Disparities2021; 8: 166–173.
Bibbins-DomingoKGrossmanDCCurrySJ, et al.Screening for colorectal cancer: US preventive services task force recommendation statement. Jama2016; 315: 2564–2575.
42.
PetersonEBOstroffJSDuHamelKN, et al.Impact of provider-patient communication on cancer screening adherence: a systematic review. Prev Med2016; 93: 96–105.
43.
Castañeda-AvilaMATisminetzkyMOyinboAG, et al.Racial and ethnic disparities in use of colorectal cancer screening among adults with chronic medical conditions: BRFSS 2012–2020. Prev Chronic Dis2024; 21: E12.
TsaiMHBevelMSAndrzejakSE, et al.Receipt of follow-up care plans on colorectal cancer screening among breast, prostate, and lung cancer survivors. J Cancer Surviv2024; 18: 781–790.
46.
Santos-TelesMModuguGSilvaIC, et al.Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample. Support Care Cancer2024; 32: 798.
47.
Ponce-ChazarriLPonce-BlandónJAImmordinoP, et al.Barriers to breast cancer-screening adherence in vulnerable populations. Cancers (Basel)2023; 15: 604.
48.
DalyJMLevyBTMossCA, et al.System strategies for colorectal cancer screening at federally qualified health centers. Am J Public Health2015; 105: 212–219.
49.
KranzAMRyanJMahmudA, et al.Association of primary and specialty care integration on physician communication and cancer screening in safety-net clinics. Prev Chronic Dis2020; 17: E134.
50.
MillerBCBowersJMPayneJB, et al.Barriers to mammography screening among racial and ethnic minority women. Soc Sci Med2019; 239: 112494.
51.
AngelovIHaasAMBrockE, et al.Cardiovascular disease and breast cancer stage at diagnosis. JAMA Netw Open2025; 8: e2452890–e2452890.
52.
KoelwynGJNewmanAACAfonsoMS, et al.Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med2020; 26: 1452–1458.
53.
MichalopoulouEMatthesKLKaravasiloglouN, et al.Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: a population-based study. Cancer Epidemiol2021; 73: 101962.
54.
HarikLYamamotoKKimuraT, et al.Patient-physician sex concordance and outcomes in cardiovascular disease: a systematic review. Eur Heart J2024; 45: 1505–1511.
55.
JerantABertakisKDFentonJJ, et al.Patient-provider sex and race/ethnicity concordance: a national study of healthcare and outcomes. Med Care2011; 49: 1012–1020.
56.
2023 Snapshot: State of the Oncology Workforce in America. JCO Oncol Pract2025;21:438–438.
SchwartzCChukwudozieIBTejedaS, et al.Association of population screening for breast cancer risk with use of mammography among women in medically underserved racial and ethnic minority groups. JAMA Netw Open2021; 4: e2123751–e2123751.
59.
MagaiCConsedineNConwayF, et al.Diversity matters: unique populations of women and breast cancer screening. Cancer2004; 100: 2300–2307.
60.
HanHRLeeJEKimJ, et al.A meta-analysis of interventions to promote mammography among ethnic minority women. Nurs Res2009; 58: 246–254.
61.
ChampionVLPaskettEDStumpTE, et al.Comparative effectiveness of 2 interventions to increase breast, cervical, and colorectal cancer screening among women in the rural US: a randomized clinical trial. JAMA Netw Open2023; 6: e2311004–e2311004.
62.
YoungBBedfordLKendrickD, et al.Factors influencing the decision to attend screening for cancer in the UK: a meta-ethnography of qualitative research. J Public Health-Uk2018; 40: 315–339.
63.
WilcoxNSAmitUReibelJB, et al.Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev CardiolSep 2024; 21: 617–631.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
